Risk of serious adverse event and fatal adverse event with molecular target anticancer drugs in cancer patients: A meta-analysis
J Cancer Res Ther
; 2020 Jan; 15(6): 1435-1449
Article
| IMSEAR
| ID: sea-213553
Texto completo:
1
Índice:
IMSEAR
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Systematic_reviews
Revista:
J Cancer Res Ther
Asunto de la revista:
Neoplasms
/
Therapeutics
Año:
2020
Tipo del documento:
Article